Pharmacists: Introductory Curriculum on Alcohol Use Disorder and Medications for Alcohol Use Disorders

Product not yet rated

  • Register
    • Administrative Staff - Free!
    • Counselor (CAADE, CADTP, CCAPP, LPC, LMHC NCC, etc.) - Free!
    • PhD - Free!
    • Nurse (MSN, LPN, RN, LVN) - Free!
    • Nurse Practitioner (APRN, DNP) - Free!
    • Pharmacist (PharmD) - Free!
    • Physician (MD) - Free!
    • Physician (DO) - Free!
    • Physician (MBBS) - Free!
    • Physician Associate (PA-C) - Free!
    • Psychologist (PsyD) - Free!
    • Social Worker (MSW, LCSW, LGSW) - Free!
    • Student/Resident/Fellow - Free!
    • Other - Free!

Pharmacists: Introductory Curriculum on Alcohol Use Disorder and Medications for Alcohol Use Disorders

Created by: American Society of Addiction Medicine

June 2026

Overview

Designed for pharmacists (PharmDs and RPhs) who support the treatment of alcohol use disorder (AUD) and medications for alcohol use disorder (MAUD), this curriculum provides the foundational knowledge needed to optimize medicationrelated AUD care. 

The target audience for this introductory level activity includes clinical healthcare professionals who prescribe medications in outpatient or inpatient settings.

This activity addresses the following ACGME Competencies: Patient Care and Procedural Skills; Medical Knowledge; Interpersonal and Communication Skills; and Systems-Based Practice

Learning Objectives

Upon completion, learners will be able to:

  1. Determine the most suitable FDA-approved medication to treat alcohol use disorder based on the patient’s clinical presentation and treatment goals.  
  2. Discuss clinical considerations for prescribing medications to treat alcohol use disorder to patients with comorbid conditions.  
  3. Recognize signs, symptoms, and risks factors for alcohol withdrawal syndrome. 

Registration Deadline: 04/25/2029

Close Access Date: 05/25/2029

Instructions

  1. Click on the Contents tab to begin this activity. 
  2. Click the first section, Screening, Goal Setting, & Conversations About Alcohol Use. On the first component, Digital Resource- Alcohol Use Disorder: Understanding Stigmatizing Language, click Download Digital Resource to get started.
  3. Expand and click each of the curriculum sections and components to review the enduring trainings, online modules, downloadable digital resources, and mini videos. 
  4. Once you've reviewed all sections, click Post-Test, Evaluation & Claim Credit section. 
    1. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
    2. Click Complete GPRA Survey to provide valuable activity feedback.
    3. Click Complete Evaluation and Complete Evaluation - Presenters to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
    4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.
  5. For Pharmacists ONLY: Complete the task entitled "Enter Pharmacist CPE Monitor Information (Pharmacists Only)". Pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist CPE Monitor Information survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact pcss@asam.org.

Note for pharmacists: For courses offering CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab.

Alyssa Falleni

Alyssa Falleni

PharmD

Alyssa Falleni, PharmD, is a clinical pharmacist who received her Doctorate of Pharmacy from the University of Rhode Island. She recently completed a two-year fellowship in Health Professions Education, Evaluation, and Research in Substance Use Disorders and Related Harms at the VA Connecticut Healthcare System. She holds a clinical instructor appointment at the Yale School of Medicine in the Department of Psychiatry and works as an outpatient HIV Pharmacist at Hartford Healthcare, Connecticut. Her research and clinical interests are in improving medication access for people who use substances and identifying and addressing social determinants of health.

No Relevant Financial Disclosures.

Joshua Lee, MD, MSc

Joshua Lee, MD, MSc

Joshua D. Lee MD, MSc is a Professor in the departments of Population Health and Medicine/General Internal Medicine and Clinical Innovation at the NYU Grossman School of Medicine. He is Director of the NYU Fellowship in Addiction Medicine and Co-Director of DPH’s Section on Tobacco, Alcohol, and Drug Use. He is a clinician-researcher focused on addiction pharmacotherapies in primary care and criminal justice populations and leads the NYUGSOM Hub of the NIDA Justice and Community Opioid Innovation Network. He is a Science Advisor at Oar Health, an alcohol treatment provider. 

Dislcosures: Indivior, in-kind study drug donation; Alkermes, in-kind study drug donation; Oar Health, Clinical Advisor

Lara Ray

Lara Ray

PhD

Dr. Lara Ray received her PhD in Clinical Psychology from the University of Colorado at Boulder. Dr. Ray completed a predoctoral clinical internship at Brown University Medical School, where she stayed for a postdoctoral fellowship at the Brown University Center for Alcohol and Addiction Studies. After her postdoctoral fellowship, Dr. Ray joined the faculty at the UCLA Clinical Psychology Program, where she is now a Full Professor. Dr. Ray also has academic appointments at the UCLA Department of Psychiatry and Human Behavior and the UCLA Brain Research Institute. Dr. Ray has an active program of research on the clinical neuroscience of addiction. Her laboratory combines experimental psychopharmacology with behavioral genetic and neuroimaging methods to ascertain the mechanisms underlying addictive disorders in humans and apply these insights to treatment development. Dr. Ray has over 250 peer-reviewed publications and book chapters. Her program of research is funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) as well as the National Institute on Drug Abuse (NIDA). Dr. Ray has received research excellence awards from the American Psychological Association (APA), the Research Society on Alcoholism (RSA), and the American College on Neuropsychopharmacology (ACNP).

No Relevant Financial Disclosures.

Melissa Weimer, Do, MCR, DFASAM

Melissa Weimer, Do, MCR, DFASAM

PCSS-MAUD Medical Director

Yale School of Medicine

Lamia Haque, MD, MPH

Lamia Haque, MD, MPH

Hepatologist, Addiction Medicine Specialist, Assistant Professor of Internal Medicine

Yale School of Medicine

No relevant financial disclosures

Julie Byler, D.O., FASAM

Julie Byler, D.O., FASAM

Adventist Improving Addiction Care Team (IMPACT) Lead

Adventist Health Portland

No Relevant Financial Disclosures

Tessa Steel

Tessa Steel

MD, MPH

Tessa Steel, MD, MPH is an Assistant Professor, physician-scientist, and Pulmonary Critical Care Medicine doctor at Harborview Medical Center, a county safety-net hospital operated by the University of Washington in Seattle. She is board-certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine. Her clinical and research interests include improving hospital-based treatments for alcohol withdrawal syndrome and using hospitalizations to help people with addiction launch their process of recovery.

No Relevant Financial Disclosures.

Stephen Holt

Stephen Holt

MD, MS, FACP

image

Accreditation & Credits

Joint Accreditation Statement

In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credits Available
  • Pharmacists: 5.25 Credits
  • Certified Counselors: NBCC Contact Hours Not Offered
    image American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
  • NAADAC: CE Credits not offered
  • Certificates for other professions

    All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.

    Disclosure Information


    In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.

    See the attached pdf for a list of disclosures.

Key:

Complete
Failed
Available
Locked
Medications for Alcohol Use Disorder
Digital Resource- Alcohol Use Disorder: Understanding Stigmatizing Language
Select the "Download Digital Resource" button to begin.  |  5 minutes
Select the "Download Digital Resource" button to begin.  |  5 minutes This infographic describes the effects of stigma and language that perpetuate negative bias against people with alcohol use disorder (AUD). It also provides examples of how to use person-first language in clinical practice to avoid stigmatizing individuals with AUD.
Complete Module: Pharmacotherapy for Alcohol Use Disorder: Best Practices and Clinical Strategies
Begin self-paced component package.
Begin self-paced component package. Enhance patient outcomes when treating alcohol use disorder (AUD) by integrating Food & Drug Administration (FDA)-approved medications into your clinical practice. This 2-hour, interactive online module provides knowledge and tools to confidently integrate pharmacotherapy into your treatment plans. It covers the FDA-approved medications for AUD, including their mechanisms of action, efficacy, and safety profiles. You'll learn how to select appropriate medications based on individual patient factors, how to initiate and monitor treatment, and strategies for promoting medication adherence.
Digital Resource: What Pharmacists Need to Know: Identification and Treatment of Unhealthy Alcohol Use and Alcohol Use Disorder
Select the "Download Digital Resource" button to begin.  |  5 minutes
Select the "Download Digital Resource" button to begin.  |  5 minutes This toolkit equips pharmacists with an overview of their unique role and evidence-based strategies for identifying and managing unhealthy alcohol use across community, ambulatory, and inpatient, settings. It describes practical approaches to screening for unhealthy alcohol use and withdrawal, providing patient education and support, facilitating referrals, and initiating or supporting medications for alcohol use disorder, along with ongoing monitoring.
Enduring Training- Systematic Review of Medications for Alcohol Use Disorder
Open to view video.  |  60 minutes
Open to view video.  |  60 minutes This video is approximately 60 minutes and was recorded on 01/30/2025.
Withdrawal, Comorbid Conditions, and Unique Approaches
Digital Resource: Medications for Alcohol Use Disorder: Considerations for Patients with Comorbid Conditions
Select the "Download Digital Resource" button to begin.  |  5 minutes
Select the "Download Digital Resource" button to begin.  |  5 minutes This infographic guides clinicians in safely prescribing MAUD to patients with a variety of comorbid conditions and situations, such as patients with liver disease, chronic kidney disease, myocardial or coronary disease, cognitive impairment, seizure disorder, HIV/HCV/HBV, co-occurring substance use, and/or pregnancy.
Mini Video: Medications for Alcohol Use Disorder in Liver Disease
Select the "View Mini Video" button to begin.  |  12 minutes
Select the "View Mini Video" button to begin.  |  12 minutes This video discusses the treatment of alcohol use disorder (AUD) in patients with liver disease. It emphasizes the critical importance of treating AUD to improve patient outcomes and prevent liver disease progression. This video explains the different stages of alcohol-associated liver disease (ALD) and highlights the considerations for prescribing medications for AUD at each stage.
Mini Video: The Sinclair Method
Select the "View Mini Video" button to begin.  |  7 minutes
Select the "View Mini Video" button to begin.  |  7 minutes This video explains the Sinclair Method, a structured, off-label approach to treating alcohol use disorder that involves taking naltrexone, an FDA-approved opioid receptor antagonist, prior to alcohol consumption. It compares the Sinclair Method to traditional and targeted naltrexone dosing, and offers guidance on identifying appropriate patients, understanding its advantages and limitations, and implementing the treatment protocol effectively.
Complete Module: Assessment and Management of Alcohol Withdrawal
Begin self-paced component package.
Begin self-paced component package. This activity will take 1.5 hour to complete. This activity was last reviewed and updated in September 2024.
Patient Support
Digital Resource: Recovery Groups List
Select the "Download Digital Resource" button to begin.  |  5 minutes
Select the "Download Digital Resource" button to begin.  |  5 minutes This factsheet offers an overview of nationally available recovery groups, also known as mutual aid, mutual help, or self-help groups, that support people seeking recovery or already in long-term recovery, along with their families and loved ones.
Post-test, Evaluation & Claim Credit
Complete Post Test
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass This post-test has 3 questions and requires 2 out of 3 questions to pass the test.
Complete GPRA Survey
Select the "Complete GPRA Survey" button to begin.
Select the "Complete GPRA Survey" button to begin. https://ttc-gpra.org/P?s=371697
Complete Evaluation
14 Questions
14 Questions Scroll down on evaluation, there may be questions that expand past the size of the window.
Claim Credit & Certificate
Up to 5.25 medical credits available  |  Certificate available
Up to 5.25 medical credits available  |  Certificate available Attendees should claim only the credit commensurate with the extent of their participation in the activity.
Enter Pharmacist CPE Monitor Information (Required for Pharmacists)
2 Questions
2 Questions Pharmacists and Pharmacist Technicians are required to enter their CPE Monitor reporting information. All other health professionals, including physicians, social workers, nurses, etc., should skip this step. Pharmacists must complete credit claim withing 30 days of completion. Failure to do so will result in credits not being reported to ACPE. ASAM will not report credits claimed 31+ days after activity completion.